Biomarkers and surrogate markers in clinical dermatology trials [MSBMM222]

Learning outcomes

Students will be able to discriminate a biomarker from a surrogate marker in the context of regulatory affairs and their importance in the interpretation of clinical trials in dermatology.

Objectives

To understand what are biomarkers and surrogate markers in dermatology, their importance in the context of regulatory affairs, and their value in the interpretation of clinical trials.

Content

Seminars given by clinicians.